<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04109612</url>
  </required_header>
  <id_info>
    <org_study_id>15117</org_study_id>
    <nct_id>NCT04109612</nct_id>
  </id_info>
  <brief_title>Improving Stroke Care in Greece in Terms of Management, Costs and Health Outcomes-</brief_title>
  <acronym>SUN4P</acronym>
  <official_title>Improving Stroke Care in Greece in Terms of Management, Costs and Health Outcomes- Stroke Units Necessity for Patients (SUN4P)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National and Kapodistrian University of Athens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hellenic Foundation for Research and Innovation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>General Secretariat for Research and Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hellenic Stroke Organization</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National and Kapodistrian University of Athens</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objectives of the proposed project are:

        1. To provide essential data on acute stroke management (quality indicators) incorporating
           hard clinical outcomes that will contribute to an ongoing process of quality improvement

        2. To develop an interactive multichannel platform, for collecting, cleansing and curating
           high quality in-hospital and follow up data, applying multidimensional quality
           assessment analysis, providing statistical and analytic reports, monitoring behavioral
           changes and supporting overall project's management.

        3. To evaluate patients' and physicians' experiences and their impact on stroke management.

        4. To assess severe negative impact of stroke on the life of survivors including quality of
           life and disability

        5. To measure health related and non- health (loss of productivity, informal care) related
           national expenditure for stroke care using a bottom up approach

        6. To evaluate the value of care focusing on health outcomes compared with total costs of
           achieving them
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective cohort multicenter study of patients with first ever acute stroke, hemorrhagic
      and ischemic, (ICD-10 codes: I61, I63 and I64) admitted within 48 hours of symptoms onset to
      seven NHS and University hospitals will be conducted. About 1,000 patients (2% of all new
      cases/annually) will be recruited from six urban and semi-urban areas with 5.5 mil people
      (50% of Greek population), reporting 25,000 discharged stroke cases annually (53% of all
      stroke discharges), according to data derived from Hellenic Statistical Authority. All
      patients will be followed for three months. Moreover, a sub-group of the 300 firstly
      recruited patients will be followed for a year to obtain data on post hospital health and
      social needs, health services utilization (medication, rehabilitation, outpatient visits) and
      productivity loss . Patient enrolment and follow up is estimated to last 18 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 17, 2019</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>Through hospitalization completion, an average of 10 days</time_frame>
    <description>Patient based stroke (inpatient and outpatient) mortality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>One month</time_frame>
    <description>Patient based stroke (inpatient and outpatient) mortality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>Three months</time_frame>
    <description>Patient based stroke (inpatient and outpatient) mortality</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Modified Rankin Scale (mRS) score</measure>
    <time_frame>Through hospitalization completion, an average of 10 days</time_frame>
    <description>mRS measures the degree of disability or dependence in the daily activities of patients after a stroke or other causes of neurological disability (0: no symptoms at all - 6: Dead)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Modified Rankin Scale (mRS) score</measure>
    <time_frame>One month</time_frame>
    <description>mRS measures the degree of disability or dependence in the daily activities of patients after a stroke or other causes of neurological disability (0: no symptoms at all - 6: Dead)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Modified Rankin Scale (mRS) score</measure>
    <time_frame>Three months</time_frame>
    <description>mRS measures the degree of disability or dependence in the daily activities of patients after a stroke or other causes of neurological disability (0: no symptoms at all - 6: Dead)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>National Institutes of Health Stroke Scale (NIHSS) score</measure>
    <time_frame>Through hospitalization completion, an average of 10 days</time_frame>
    <description>NIHSS is a method for assessing the severity of a stroke experienced by a patient (0: No Stroke Symptoms, 42:Severe Stroke)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>National Institutes of Health Stroke Scale (NIHSS) score</measure>
    <time_frame>One month</time_frame>
    <description>NIHSS is a method for assessing the severity of a stroke experienced by a patient (0: No Stroke Symptoms, 42: Severe Stroke)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>National Institutes of Health Stroke Scale (NIHSS) score</measure>
    <time_frame>Three months</time_frame>
    <description>NIHSS is a method for assessing the severity of a stroke experienced by a patient (0: No Stroke Symptoms, 42: Severe Stroke)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cost</measure>
    <time_frame>Through hospitalization completion, an average of 10 days</time_frame>
    <description>Average cost per patient</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cost</measure>
    <time_frame>One month</time_frame>
    <description>Average cost per patient</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cost</measure>
    <time_frame>Three months</time_frame>
    <description>Average cost per patient</description>
  </primary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Cerebrovascular Disorders</condition>
  <eligibility>
    <study_pop>
      <textblock>
        About 1,000 first ever stroke patients (2% of all new cases/annually) will be recruited
        from six urban and semi-urban areas with 5.5 mil people (50% of Greek population),
        reporting 25,000 discharged stroke cases annually. All patients will be followed for three
        months.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of hemorrhagic or ischemic stroke (ICD-10: I61, I63 and I64)

          -  Patients with First ever acute stroke
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>OLGA SISKOU, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Senior Researcher on Health and Nursing Economics and Management</affiliation>
  </overall_official>
  <overall_official>
    <last_name>GEORGE NTAIOS, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Head of Physicians /Nurses Team</affiliation>
  </overall_official>
  <overall_official>
    <last_name>GEORGE PAPASTEFANATOS, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Head of IT Team</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National and Kapodistrian University of Athens</name>
      <address>
        <city>Athens</city>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Aiginiteio Hospital of Athens</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ARGYRO TOUNTOPOULOU, PhD</last_name>
      <phone>00302107289400</phone>
      <email>atounto@yahoo.gr</email>
    </contact>
    <investigator>
      <last_name>ARGYRO TOUNTOPOULOU</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>IOANNA KOUZI</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General Hospital of Athens Alexandra</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ELENI KOROMPOKI, PhD</last_name>
      <phone>00302132162000</phone>
      <email>e.korompoki@imperial.ac.uk</email>
    </contact>
    <investigator>
      <last_name>ELENI KOROMPOKI</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>EFSTATHIOS MANIOS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>ANASTASIA VEMMOU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hellenic Stroke Organization</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Chania General Hospital St George</name>
      <address>
        <city>Chania</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JOHN KALIONTZAKIS, MD</last_name>
      <phone>00302821022000</phone>
      <email>jkaliontzis@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>JOHN KALIONTZAKIS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>ASPASIA KOURIDAKI</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University General Hospital of Ioannina</name>
      <address>
        <city>Ioannina</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>HARALAMPOS MILIONIS, PhD</last_name>
      <phone>00302651099111</phone>
      <phone_ext>00302651099111</phone_ext>
      <email>hmilioni@uoi.gr</email>
    </contact>
    <investigator>
      <last_name>HARALAMPOS MILIONIS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>XARA EVAGGELOU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General University Hospital of Larisa</name>
      <address>
        <city>Larisa</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>GEORGE NTAIOS, PhD</last_name>
      <phone>00302413501000</phone>
      <email>gntaios@med.uth.gr</email>
    </contact>
    <investigator>
      <last_name>GEORGE NTAIOS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>EFSTATHIA KARAGKIOZI</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University General Hospital of Thessaloniki Ahepa</name>
      <address>
        <city>Thessaloniki</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>APOSTOLOS HATZITOLIOS, PhD</last_name>
      <phone>00302310994918</phone>
      <email>axatzito@med.auth.gr</email>
    </contact>
    <contact_backup>
      <last_name>CHRISTOS SAVVOPOULOS, PhD</last_name>
      <phone>00302310994918</phone>
      <email>chrisavopoulos@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>APOSTOLOS HATZITOLIOS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>CHRISTOS SAVVOPOULOS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>ATHINA MYROU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General Hospital of Tripoli Evaggelistria</name>
      <address>
        <city>Tripoli</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>EVANGELOS TSAMPALAS, MD</last_name>
      <phone>00302713601700</phone>
      <email>tsampalas_e65@yahoo.gr</email>
    </contact>
    <investigator>
      <last_name>EVANGELOS TSAMPALAS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>HELEN ALEXOPOULOU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>September 27, 2019</study_first_submitted>
  <study_first_submitted_qc>September 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 30, 2019</study_first_posted>
  <last_update_submitted>October 1, 2019</last_update_submitted>
  <last_update_submitted_qc>October 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National and Kapodistrian University of Athens</investigator_affiliation>
    <investigator_full_name>Olga Ch. Siskou RN, MSc, PhD</investigator_full_name>
    <investigator_title>Senior Researcher</investigator_title>
  </responsible_party>
  <keyword>stroke</keyword>
  <keyword>stroke care</keyword>
  <keyword>stroke units</keyword>
  <keyword>value of stroke care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Cerebrovascular Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

